Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
6
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
6
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
gene therapy
indiana blog main
indiana top stories
glaxosmithkline
nonalcoholic steatohepatitis
cancer immunotherapy
clinical trials
deals
europe blog main
europe top stories
gilead sciences
merck
parkinson's disease
philadelphia blog main
What
bio
6
×
cancer
6
×
roundup
amid
bombast
caught
coronavirus
debate
develop
discussion
efforts
immunotherapy
meso’s
miss
pandemic
pfizer’s
presidential
promise
response
tuesday’s
vaccine
viewers
abbvie’s
advanced
ahead
allogene
appetite
arrival
award
biofourmis
black
bread
bucks
butter
buyout
cash
celebrate
chance
corner
crispr
Language
unset
Current search:
bio
×
" san francisco top stories "
×
" raleigh-durham top stories "
×
cancer
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More